Assessing the views and opinions of psychiatric patients receiving genome-guided treatment within the scope of the PREPARE preemptive pharmacogenomics clinical study

Collectively, our data highlights the need for enhanced patient education and awareness about PGx testing and reflects an overall positive patient attitude towards genome-guided therapeutics.